HLS Therapeutics Inc (TSX:HLS)
C$ 4.32 -0.10 (-2.26%) Market Cap: 138.24 Mil Enterprise Value: 182.98 Mil PE Ratio: 0 PB Ratio: 1.68 GF Score: 62/100

HLS Therapeutics Inc (TSX:HLS) Transcripts

  • 1